Tudor Investment Corp’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-129,522
Closed -$20.3M 3963
2025
Q3
$17.3M Buy
129,522
+76,767
+146% +$9.32M 0.03% 502
2025
Q2
$6.56M Buy
+52,755
New +$6.71M 0.01% 920
2023
Q4
Sell
-5,123
Closed -$815K 2810
2023
Q3
$815K Buy
+5,123
New +$837K 0.01% 1412
2022
Q1
Sell
-1,606
Closed -$425K 2563
2021
Q4
$425K Buy
+1,606
New +$433K 0.01% 1590
2021
Q2
Sell
-4,759
Closed -$925K 1884
2021
Q1
$925K Sell
4,759
-2,063
-30% -$423K 0.02% 872
2020
Q4
$1.31M Buy
+6,822
New +$1.24M 0.04% 588
2020
Q2
Sell
-7,051
Closed -$681K 1379
2020
Q1
$681K Buy
+7,051
New +$681K 0.06% 371
2019
Q2
Sell
-45,742
Closed -$2.7M 1299
2019
Q1
$2.7M Buy
45,742
+23,798
+108% +$1.37M 0.11% 197
2018
Q4
$1.16M Buy
+21,944
New +$1.29M 0.02% 343
2017
Q3
Sell
-23,752
Closed -$984K 1223
2017
Q2
$984K Buy
+23,752
New +$903K 0.03% 342
2016
Q3
Sell
-13,444
Closed -$368K 1676
2016
Q2
$368K Buy
13,444
+3,954
+42% +$101K 0.01% 1041
2016
Q1
$255K Sell
9,490
-3,320
-26% -$81.2K 0.01% 1382
2015
Q4
$362K Buy
12,810
+3,279
+34% +$94.6K 0.01% 1118
2015
Q3
$265K Buy
9,531
+2,035
+27% +$73.5K 0.01% 1183
2015
Q2
$309K Sell
7,496
-2,600
-26% -$95.3K 0.01% 1082
2015
Q1
$307K Buy
+10,096
New +$262K 0.01% 1040
2014
Q2
Sell
-24,627
Closed -$317K 1291
2014
Q1
$317K Buy
+24,627
New +$353K 0.01% 776

Other funds holding RGEN

Tudor Investment Corp's RGEN Position: Q4 2025 in Review

Tudor Investment Corp sold out of Repligen (RGEN) in Q4 2025, closing a stake of 129,522 shares — an estimated $20.3M sold.

Tudor Investment Corp first reported a position in RGEN in Q1 2014 and held it in 17 quarters. The position peaked at $17.3M in Q3 2025. 473 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

  • Tudor Investment Corp reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 129,522 Repligen shares in Q4 2025, an estimated $20.3M.
  • Tudor Investment Corp first reported a position in Repligen in Q1 2014 and held it in 17 quarters.
  • Tudor Investment Corp's Repligen position peaked at $17.3M in Q3 2025.
  • 473 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.